1. Lou A, Elnenaei M, Liu E, et al. Evaluation of a novel albumin platelet product (APP) fibrosis index and three ...

When damage to the liver caused by alcohol or viral infections persists, liver fibrosis progresses and replaces tissue with ...

At the Liver Meeting sponsored by the American Association for the Study of Liver Diseases, investigators presented new ...

A new mouse study shows high-dose aluminum adjuvant Imject Alum can induce liver fibrosis via inflammasome activation, ...

In phase 2 trials involving patients with stage 2 or 3 fibrosis caused by metabolic dysfunction–associated steatohepatitis (MASH), efruxifermin, a bivalent fibroblast growth factor 21 (FGF21) analogue ...

Discover how Fibulin-5 could serve as a new blood-based marker for early liver fibrosis diagnosis and potential treatment ...

Professor Kim Jeong-han (co-corresponding author) and Dr. Jay H. Chung (co-corresponding author) of the National Institute of Health (NIH) have discovered therapeutic targets that can dramatically ...

In 1980, Ludwig and colleagues described the histologic features of a newly identified chronic liver condition referred to as nonalcoholic steatohepatitis (NASH) and noted that the majority of the ...

Congenital hepatic fibrosis is a type of liver disease that is present from birth. It typically affects the function of the bile ducts and the veins that carry blood from the digestive tract to the ...

When damage to the liver caused by alcohol or viral infections persists, liver fibrosis progresses and replaces tissue with collagen fibers. This is ...